S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Clinical trial NCT02134912 · TERMINATED
Trial details
- NCT number
- NCT02134912
- Sponsor
- SWOG Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.